Epithelial Ovarian Carcinoma Types and the Coexistence of Ovarian Tumor Conditions

Niekerk, Catharina C. van; Bulten, Johan; Dijck, José A. A. M. van; Verbeek, A.L.M.

doi:10.5402/2011/784919

Cited by 4 publications

(5 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Owing to the anatomic location of the ovary that make it inaccessible for screening and the nonspecific symptoms of its tumors, the majority of the patients present with advanced disease, making prognosis poor. 14 In this study, most of the patients(61%) had stage lll disease and no patient in stage IV diseases after sugicopathological evaluation. Epithelial ovarian cancer (74%) was the most common histological type.…”

Section: Resultsmentioning

confidence: 57%

Clinical Audit of Gynecological Cancers at National Institute of Cancer Research and Hospital, Dhaka, Bangladesh

Haque,

Pervin,

Ara

et al. 2024

J. Bangladesh Coll. Phys.

View full text Add to dashboard Cite

The aim of this audit was to assess the trend of the gynecological cancers for the year of 2022. This is an observational study on retrospectively collected data of gynecological cancer patients at National Institute of Cancer Research and Hospital (NICRH), Dhaka. All cases of cancer seen at the gynecology outpatient department and cases admitted in the gynecological oncology ward at NICRH, between the months of January to December 2022 were audited. The results shown that about 5.8% of all the new cases were young women aged below 25 years. The majority of gynecological cancers were among women aged between 35 and 64 years (73.17%) and only 2.6% patients were aged above 75 years. Cervical cancer (59%) was the leading gynecological cancer among all female cancers attended at NICRH. In ovarian malignancy, most of the patients(61%) had stage lll disease and no patient in stage IV diseases. Due to improper evaluation of abnormal uterine bleeding, majority of the endometrial carcinoma patients (64%) presented with histopathology reports after hysterectomy. This study might help to get a in depth understanding of the trend of major gynecological cancers. J Bangladesh Coll Phys Surg 2024; 42: 43-48

show abstract

Section: Resultsmentioning

confidence: 57%

Clinical Audit of Gynecological Cancers at National Institute of Cancer Research and Hospital, Dhaka, Bangladesh

Haque,

Pervin,

Ara

et al. 2024

J. Bangladesh Coll. Phys.

View full text Add to dashboard Cite

show abstract

“…Indonesian Journal of Clinical Pathology and Medical Laboratory, 2019 March, 25 (2) : 184 -190 The biology of ovarian carcinoma, furthermore, is different from hematogenous tumors since ovarian cancer cells mainly spread in the peritoneal cavity and are only superficially invasive. But, when tumors that proliferate rapidly suppress the visceral organs and only chemosensitivity is temporary, ovarian carcinoma becomes a deadly disease with a cure rate of only 30%.…”

Section: Page 187mentioning

confidence: 99%

“…Indonesian Journal of Clinical Pathology and Medical Laboratory, 2019 March, 25 (2) : 184 -190 progression-related processes, such as tumor growth, 13 invasion, and neoangiogenesis.…”

Section: Page 188mentioning

confidence: 99%

D-Dimer and Fibrinogen in Patients Underwent Surgery in Malignant and Benign Ovarian Tumor

Aswin

Hariman²,

Sahil

2019

Indonesian J. Clin. Pathol. Med. Lab.

View full text Add to dashboard Cite

Ovarian tumour ranks second in gynecology tumour cases and ranks second in gynecology tumour death in Indonesia. Tumour cause hypercoagulable that increase risk of thrombosis by procoagulant mechanism. Tumout cells also can cause hyperfibrinogenemmia that can cause bleeding. The aim of study was to know D-dimer and fibrinogen value to investigate primary hyperfibrinolysis on malignant and benign ovarian tumour; and to know whether operation procedure on malignant and benign tumour change D-dimer and fibrinogen value. Prospective analysis study, subject were malignant and benign ovarian tumour patients undergoing surgery in Haji Adam Malik Hospital, Medan. One way Annova test dan Wilcoxon Sum-Rank test were performed. Stastical differentiation is indicate with p<0,05. Study subject was 16 patient where 8 malignant and benign ovarian tumour patient respectively. Malignant ovarian tumour D-dimer values was higher than benign ovarian tumour (p<0,01) that indicate fibrinolysis increase in malignant ovarian tumour. Malignant ovarian tumour fibrinogen values as same as benign ovarian tumour (p>0,05) that indicate the fibrinolysis in ovarian tumour wasn’t primary hyperfibrinolysis. Surgery procedure didn’t influence D-dimer and fibrinogen values. Primary hyperfibrinolysis wasn’t occur in ovarian tumour.Keywords : Ovarian tumour, malignant, benign, D-dimer, fibrinogen.

show abstract

“…[ 1 ] Due to the anatomic location of the ovaries making it inaccessible for testing, lack of a proper screening method and the non-specific symptoms of its tumors, the majority of the patients present in advanced stage; leading to increased morbidity and mortality. [ 2 ] Preoperative histologic confirmation of malignant ovarian tumors is mandatory before chemotherapy. Biopsy is advised in patients with either primarily inoperable pelvic tumor, advanced tumor with compromised performance status or recurrent tumors.…”

Section: Introductionmentioning

confidence: 99%

Trucut biopsy vs FNAC of pelvic tumors-who wins the match?

Kar

Satapathy²,

Pattnaik

et al. 2018

J Cytol

View full text Add to dashboard Cite

Preoperative pathologic diagnosis of pelvic tumors is mandatory for proper management of patients like neoadjuvant chemotherapy and interval debulking. Currently there are many minimally invasive methods available which include fine-needle aspiration cytology (FNAC) and trucut biopsy, mostly complimentary to each other. FNAC is a cheap, rapid and sensitive method for diagnosis of pelvic tumors. It can be done as an outpatient procedure without complications. But with it, the tissue architecture cannot be seen. Trucut biopsy on the other hand reveals tissue architecture and can help in grading and subtyping of malignant tumors. Trucut biopsy has to be done under image guidance like ultrasound and computed tomography. Patient is administered local anaesthetic and can be discharged safely after 2 hours. Pathologists familiar with histomorphology can give a correct diagnosis easily. But many times sampling errors may occur; especially in large tumors, resulting only in necrosis, hemorrhage and degenerated tissue bits. Also differentiation of borderline from malignant ovarian tumors is very difficult. In case of mixed tumors one component may be missed. Hard tumors like fibromas and leiomyomas yield scanty material and result in inadequate reporting. With FNAC, the overall accuracy rate is estimated to be around 96.3%. With trucut biopsy, adequacy is from 91 to 95% and accuracy is approximately 98% in different studies. When both methods are combined, the adequacy is 100%, diagnostic accuracy 95.5%, sensitivity 94.9% and specificity 100%. Therefore depending on the clinical diagnosis and the location of tumors, either FNAC and/or trucut biopsy can be chosen.

show abstract

Epithelial Ovarian Carcinoma Types and the Coexistence of Ovarian Tumor Conditions

Cited by 4 publications

References 18 publications

Clinical Audit of Gynecological Cancers at National Institute of Cancer Research and Hospital, Dhaka, Bangladesh

Clinical Audit of Gynecological Cancers at National Institute of Cancer Research and Hospital, Dhaka, Bangladesh

D-Dimer and Fibrinogen in Patients Underwent Surgery in Malignant and Benign Ovarian Tumor

Trucut biopsy vs FNAC of pelvic tumors-who wins the match?

Contact Info

Product

Resources

About